TD Cowen initiated coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Free Report) in a research report released on Monday morning, MarketBeat.com reports. The firm issued a buy rating on the stock.
Tectonic Therapeutic Trading Down 5.3 %
Tectonic Therapeutic stock opened at $16.10 on Monday. Tectonic Therapeutic has a 52 week low of $10.56 and a 52 week high of $19.80.
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) earnings per share (EPS) for the quarter.
Read More
- Five stocks we like better than Tectonic Therapeutic
- What is the S&P/TSX Index?
- The Top 3 Sectors Poised For Growth This Summer
- High Flyers: 3 Natural Gas Stocks for March 2022
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- ESG Stocks, What Investors Should Know
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for Tectonic Therapeutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tectonic Therapeutic and related companies with MarketBeat.com's FREE daily email newsletter.
